Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia.

Francis Joseph Giles

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

Abstract

To investigate the toxicity profile, activity, and pharmacokinetics of a novel L-nucleoside analog, troxacitabine (BCH-4556), in patients with advanced leukemia.
Original languageEnglish (Ireland)
Number of pages10
JournalJournal Of Clinical Oncology
Volume19
Issue number3
Publication statusPublished - 1 Feb 2001

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • Giles FJ, Cortes JE, Baker SD, Thomas DA, O'Brien S, Smith TL, Beran M, Bivins C, Jolivet J, Kantarjian HM

Fingerprint

Dive into the research topics of 'Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia.'. Together they form a unique fingerprint.

Cite this